VEGFA and Behcet disease: Therefore, the main aim of this current study, which employed a real-world design, is to determine the role of plasma VEGF concentrations in the antianhedonic effects of repeated-dose intravenous ketamine (0.5 mg/kg) administered thrice weekly over 2 weeks, focusing on Chinese subjects experiencing treatment-refractory MDD or BD.